In the area of medical devices, we obtain a broad product portfolio- Minimally Invasive treatment product, Aesthetic Lasers Product, Respiratory medical Product, Dental product…etc.
- Sisram is a globally leading company of energy-based medical aesthetic treatment system. In September 2017, Sisram was listed on the main board of the Hong Kong Stock Exchange and became the first Israeli company listed on the main board of the Hong Kong Stock Exchange.
- Da Vinci surgical robotic system nominees by Chindex Medical Limited (CML), is the only Robotic Product of Minimally Invasive laparoscopy Surgery approved by the FDA in the United States and authorized by China Food and Drug Administration. In 2017, medical beauty devices and dental digitized product maintained rapid growth. The number of surgeries by Da Vinci surgical robotic system sustained rapid growth and amounted to over 28,000 in Mainland China and Hong Kong, representing year-on-year growth of approximately 46% as compared to 2016.
- The joint venture was already established by the Company and Intuitive Surgical in Shanghai, to develop and manufacture minimally invasive robotic products for the early diagnosis and treatment of lung cancer.
- The digital product line for dentistry maintained a rapid growth.
Fosun Pharma is one of the earliest companies that work on in vitro diagnostics (IVD) in China. Their products cover clinical chemistry, clinical immunology, molecular diagnostics (including DNA microarray), clinical microbiology and other laboratory medicine fields. These are currently leading products in the field of medical diagnosis in China. Fosun is a service provider in China and a participant in the international market.
- Owns several strong brands including “Long March” and “Yaneng”.
- The single largest shareholder of Saladax Biomedical of the United States. Saladax Biomedical is a privately held company developing and commercializing novel personalized chemotherapy dosing for cancer patients
- Work with Korean company SD Biosensor on rapid diagnosis platform so as to extend the scope of our diagnostic business.
- Fosun Pharma has invested in miacom diagnostics GmbH, a German company focusing on developing a novel and rapid diagnostic platform for multiplex assays identify and differentiate most of the microorganisms. Genefirst Limited, a UK company specializing in developing and manufacturing molecular diagnostic products for infectious diseases and cancers, Oxford Immunotec, a UK company specializing in detecting specific cell responses to various diseases based on the technological platform of the University of Oxford with the most advanced test for tuberculosis infection, and Astute, an American firm specializing in the development of innovative markers for the detection of high-risk acute diseases.
About other business of Fosun Pharma